Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.4 - $0.91 $800 - $1,820
2,001 Added 1.32%
153,309 $81,000
Q4 2023

Feb 13, 2024

BUY
$0.71 - $0.97 $13,960 - $19,073
19,663 Added 14.94%
151,308 $137,000
Q3 2023

Nov 13, 2023

BUY
$0.96 - $2.01 $6,293 - $13,177
6,556 Added 5.24%
131,645 $129,000
Q2 2023

Aug 04, 2023

BUY
$1.59 - $2.29 $712 - $1,025
448 Added 0.36%
125,089 $218,000
Q1 2023

May 12, 2023

BUY
$2.05 - $2.87 $5,086 - $7,120
2,481 Added 2.03%
124,641 $284,000
Q4 2022

Feb 10, 2023

SELL
$2.06 - $3.47 $916 - $1,544
-445 Reduced 0.36%
122,160 $263,000
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $109,574 - $215,777
42,144 Added 52.38%
122,605 $351,000
Q2 2022

Aug 12, 2022

BUY
$2.19 - $3.98 $176,209 - $320,234
80,461 New
80,461 $200,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $823M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.